RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Estimation of time to reach RRMS EDSS health states >= 7.0 Or SPMS for delayed-release dimethyl fumarate
Walker, A., Berling, M., Malmenas, M., Brodtkorb, T.-H., & Alvarez-Reyes, M. (2015). Estimation of time to reach RRMS EDSS health states >= 7.0 Or SPMS for delayed-release dimethyl fumarate. Value in Health, 18(3), A279. https://doi.org/10.1016/j.jval.2015.03.1632
Multiple sclerosis (MS) disease progression is measured by the Expanded Disability Status Scale (EDSS). UK MS clinical guidelines1recommend that patients discontinue treatment with disease modifying therapies (DMTs) on reaching EDSS ?7.0, or experiencing non-relapsing secondary progressive MS (SPMS). This study derived the time for patients to reach EDSS ?7.0 or SPMS from EDSS 4.0 or 5.0, for patients treated with delayed-release dimethyl fumarate 240mg (DMF; also known as gastro-resistant DMF), or no DMT treatment.